Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
This study has been terminated.
Study NCT00134667
Information provided by Eyetech Pharmaceuticals
First Received on August 24, 2005.
Last Updated on January 12, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
